PUBLISHER: SkyQuest | PRODUCT CODE: 1244257
PUBLISHER: SkyQuest | PRODUCT CODE: 1244257
US Secondary Hyperparathyroidism (Shpt) Treatment Market Size, Share, Growth Analysis, By Drug Class Analysis(Calcimimetics, Vitamin D Analogues), By Distribution Channels(Hospital & Retail Pharmacies, Online Channel) - Industry Forecast 2022-2028
US secondary hyperparathyroidism shpt treatment market size was valued at USD 5.15 billion in 2021, and it is expected to reach a value of USD 19.42 billion by 2028, at a CAGR of 9% over the forecast period (2022 - 2028).
The prolonged increases in biochemical markers of mineral metabolism that result in the release of excessive amounts of parathyroid hormone are the hallmark of secondary hyperparathyroidism (SHPT). Those with chronic kidney disease (CKD) and those who require renal replacement therapy are both affected by secondary hyperparathyroidism. According to current estimates from the Centers for Disease Control and Prevention (CDC), 37 million Americans, or 15% of adult Americans, have CKD. Additionally, it has been noted that people 65 and older are more likely than people 45 to 64 to have CKD. For secondary hyperparathyroidism, increasing patient numbers are associated with increasing treatment costs.
Although though drugs are routinely prescribed for SHPT, surgery is recommended in challenging instances when the thyroid glands produce too much PTH. Despite the fact that surgical treatments have shown better treatment accuracy, they are less popular due to their high cost and the availability of effective drugs on the market. Medication for SHPT is covered by the Medicare national insurance programme in the US. In January 2018, medication for the management of SHPT was added to the Part B package of Medicare Insurance. Several nonprofit organisations in the United States assist patients who lack insurance or have insufficient coverage, greatly reducing the price of SHPT treatment for everyone. People still incur large out-of-pocket expenses even when the government offers health insurance through public programmes.
Top-down and bottom-up approaches were used to estimate and validate the size of US secondary hyperparathyroidism shpt treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report
The US secondary hyperparathyroidism treatment market has been segmented based on drug class analysis, distribution channels, and region. Based on drug class analysis, the market is segmented into calcimimetics, Vitamin D analogues, and phosphate binders. Based on the distribution channel, the market is segmented into hospital & retail pharmacies, online channel, and others. Based on region, the US secondary hyperparathyroidism treatment market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Driver
- The development of SHPT coexists with vitamin D insufficiency. More than 97 percent of ESRD patients, according to OPKO Health, Inc., show indications of vitamin D deficiency, which is a crucial indicator that SHPT is developing in the patient. Hence, it is projected that the rise in the prevalence of chronic disorders brought on by a sedentary lifestyle will propel the SHPT treatment market in the U.S. Another important factor propelling the secondary hyperparathyroidism (SHPT) treatment market in the United States is the government's commitment to create guidelines to improve secondary hyperparathyroidism treatment management. Controlling the biochemical markers of mineral and bone metabolism, which have a strong epidemiologic link to cardiovascular events and bone fractures, is the main objective of SHPT therapy.
Restraint
- Doing genetic testing at one's homecare is still a convenient location, among other things, is limiting the market from increasing despite the many advantages of these procedures, such as the choice of early and preventative therapy. Concerns about and oversight of the privacy of the patient's genetic information, such as DNA data, are one of the most significant growth-restraining factors in the business. This is crucial since a significant portion of secondary hyperparathyroidism SHPT treatment involves it. Clients give up their right to control and choice over their genetic data, which includes information produced from the genetic material from which they were tested. These factors are predicted to limit how these diagnostics are used, hence limiting market growth throughout the estimated time period in the U.S.
Market Trends
- As medical professionals and clinical specialists have learned more about SHPT, the management strategy for the ailment has been improved. The market expansion for treatments for this ailment would benefit from early detection and assessment of secondary hyperparathyroidism for mineral metabolism in CKD and ESRD. It is projected that the market will expand more swiftly over the projection period due to a decline in problems with SHPT management.
Table of Contents
Executive Summary
Market overview
- Exhibit: Executive Summary - Chart on Market Overview
- Exhibit: Executive Summary - Data Table on Market Overview
- Exhibit: Executive Summary - Chart on Global US secondary hyperparathyroidism shpt treatment market Characteristics
- Exhibit: Executive Summary - Chart on Market by Geography
- Exhibit: Executive Summary - Chart on Market Segmentation
- Exhibit: Executive Summary - Chart on Incremental Growth
- Exhibit: Executive Summary - Data Table on Incremental Growth
- Exhibit: Executive Summary - Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy-scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global US secondary hyperparathyroidism shpt treatment market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global US secondary hyperparathyroidism shpt treatment market by Drug Class Analysis
- Market segments
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Data table on Market share 2021-2027 (%)
- Calcimimetics
- Market Estimates & Forecast, 2020-2027
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Vitamin D Analogues
- Market Estimates & Forecast, 2020-2027
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Phosphate Binders.
- Market Estimates & Forecast, 2020-2027
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Global US secondary hyperparathyroidism shpt treatment market by Distribution Channels
- Market segments
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Data table on Market share 2021-2027 (%)
- Hospital & Retail Pharmacies
- Market Estimates & Forecast, 2020-2027
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Online Channel
- Market Estimates & Forecast, 2020-2027
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Others
- Market Estimates & Forecast, 2020-2027
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Amgen Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
- Genzyme Corporation (Sanofi) (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
- AbbVie Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
- Cipla Inc. (India)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
- Dr. Reddy's Laboratories Ltd. (India)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
- OPKO Health, Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
